Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (4) Blankenstein, Thomas Prof. Dr. (1) Cakmak-Görür, Nese Dr. (1) Dörr, Jan Rafael (1) Haas, Simon Dr. rer. nat. (4) Holz, Maximilian (1) Höpken, Uta Elisabeth PD Dr. (1) Horne, Arik (1) Janz, Martin Dr. (5) Kempa, Stefan Dr. (1) Mathas, Stephan Dr. (4) Mertins, Philipp Dr. (3) Na, Il-Kang Dr. (3) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (8) Popp, Oliver Dr. (2) Rhein, Simone Dr. (2) Sapozhnikova, Valeriia (1) Schmitt, Clemens Prof. Dr. (2) Solé Boldo, Llorenc Dr. rer. nat. (1) Strzelecka, Paulina Maria (1) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (1) Yousefian, Schayan (2) Ziehm, Matthias Dr. (1) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2019 (1) 2020 (11) 2021 (18) 2022 (21) 2023 (19) 2024 (17) Advanced Light Microscopy (44) AG Müller/Dechend (ECRC) (486) AG Schreiber [ECRC] (61) Allosteric Proteomics Lab (20) Anchored Signalling (115) Angiogenesis & Metabolism Laboratory (59) Animal Phenotyping (51) Biobank (442) Bioinformatics and Omics Data Science (93) Bioinformatics of RNA Structure and Transcriptome Regulation (50) Biology of Malignant Lymphomas (101) Biomedical Image Analysis (58) Cancer Genetics and Cellular Stress Responses (98) Cardiac MRI (292) Cardiovascular-Hematopoietic Interaction (17) Cell Biology of Immunity (67) Cellular Neurosciences (460) Chemical Biology (630) Chromatin (dys)function in disease (20) Clinical Research Unit (22) Computational and developmental biology (7) Computational methodologies and omic analytics (16) Computational Regulatory Genomics (175) Cryo-Electron Microscopy (18) Developmental Biology / Signal Transduction (217) Developmental Neurobiology (110) Development and Function of Neural Circuits (36) Electron Microscopy (13) Epigenetic Regulation and Chromatin Architecture (135) Experimental Ultrahigh-Field MR (349) Flow Cytometry (8) From Cell States to Function (10) Gastrointestinal Barrier, Regeneration and Carcinogenesis (47) Genetics and Genomics of Cardiovascular Diseases (441) Genetics of Congenital Heart Disease (69) Genetics of Metabolic and Reproductive Disorders (24) Genome Diversification & Integrity (29) Genome Engineering & Disease Models (160) Genome instability and somatic mosaicism (44) Genomics (390) Host-microbiome factors in cardiovascular disease (150) Hypertension-caused End-Organ Damage (486) Hypertension-Mediated End-Organ Damage (486) Image Data Analysis (17) immune Cell Function in Health and Disease (49) Immune Mechanisms and Human Antibodies (20) Immune Regulation and Cancer (98) Innate Immunity & Neuroinflammation (71) In Situ Structural Biology (59) Integrative Vascular Biology (166) Interdisciplinary Retina Research (116) Intracellular Proteolysis (137) Kidney Cell Engineering (18) Magnetic Resonance (349) Mathematical Cell Physiology (126) Mathematical Modelling of Cellular Processes (62) (-) Mechanism-based Cancer Therapies (94) Microenvironmental Regulation in Autoimmunity and Cancer (86) Mobile DNA (192) Molecular and cellular basis of behavio (9) Molecular Biology of Peptide Hormones (797) Molecular Cardiovascular Research (207) Molecular Epidemiology (442) Molecular Genetics of Chronic Inflammation and Allergic Disease (90) Molecular Immunology and Gene Therapy (239) Molecular mechanisms of environment sensing (13) Molecular Oncology (27) Molecular Pathways in Cortical Development (30) Molecular Physiology of Somatic Sensation (178) Myology (138) Nephrology and Inflammatory Vascular Diseases (160) Neural Circuits and Behaviour (65) Neuroimmunology Laboratory (52) Neurovascular link in neuroendocrine tumors (8) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (29) Organoids (14) Out-patient Clinic for Neuroimmunology (723) Pancreatic Organoid Research and Disease Modeling (132) Pathogenesis of ANCAinduced Glomerulonephritis (116) Pluripotent Stem Cells (78) Protein Production and Characterization (29) Proteome Dynamics (146) Proteomics (148) Proteomics and Metabolomics (107) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (380) Psychoneuroimmunology (52) Quantitative Developmental Biology (54) Quantitative Stem Cell Biology (31) RNA Biology and Posttranscriptional Regulation (155) Screening Unit (630) Single Molecule Biophysics probing Quantitative Neuroscience (13) Spatial Proteomics (27) Stem Cell Dynamics and Mitochondrial Genomics (47) Stem Cell Modeling of Development and Disease (22) Structural Biology of Membrane-Associated Processes (115) Synaptic Transmission and Plasticity (224) Systems Biology Imaging (38) Systems biology of cardiovascular and neuronal pathologies (12) Systems Biology of Gene Regulatory Elements (200) Systems Hematology, Stem Cells & Precision Medicine (49) Transgenics (160) Translational Approaches in Heart Failure and Cardiometabolic Disease (125) Translational Bioinformatics (126) Translational Cardiology and Functional Genomics (104) Translational Neuroimmunology (61) Translational Oncology of Solid Tumors (921) Translational Organ Models (88) Translational Tumorimmunology (33) Tumor heterogeneity and treatment resistance in pediatric cancer (8) 94 Results: Active Filter: Mechanism-based Cancer Therapies Sort: Result score Newest to oldest Oldest to newest June 23, 2022 / Methods Mol Biol TCR gene therapy for cancer S. Rhein N. Çakmak-Görür February 28, 2023 / Blood Adv SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma G.J.J.E. Heynen F. Baumgartner M. Heider U. Patra M. Holz J. Braune M. Kaiser I. Schäffer S.A. Bamopoulos E. Ramberger A. Murgai Y.L.D. Ng U.M. Demel D. Laue S. Liebig J. Krüger M. Janz A. Nogai M. Schick P. Mertins S. Müller F. Bassermann J. Krönke U. Keller M. Wirth November 05, 2021 / Front Oncol Survey of long-term experiences of sperm cryopreservation in oncological and non-oncological patients: usage and reproductive outcomes of a large monocentric cohort N. Lackamp I. Wilkemeyer I. Jelas U. Keller L. Bullinger S. Stintzing P. le Coutre October, 2021 / Hemasphere The mTOR inhibitor temsirolimus added to rituximab combined with dexamethasone, cytarabine, and cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL - results from the phase-II STORM trial M. Witzens-Harig A. Viardot U. Keller J. Wosniok O. Deuster J. Klemmer A.M. Geueke J. Meißner A.D. Ho J. Atta R. Marks P. La Rosée C. Buske M.H. Dreyling G. Hess February, 2022 / Leuk Lymphoma Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial D. Kaddu-Mulindwa V. Lesan C. Berdel S. Stilgenbauer M. Bewarder L. Thurner M. Witzens-Harig A. Viardot M. Soekler U. Keller L. Truemper K. Christofyllakis O. Fleser J.T. Bittenbring V. Poeschel G. Held P. Jagoda January 25, 2022 / Blood Adv MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma J. Stroh A. Seckinger M. Heider M. Rudelius R. Eichner M. Schick J. Slawska M. Emde H. Salwender U. Bertsch H. Goldschmidt K.C. Weisel C. Scheid U. Keller D. Hose F. Bassermann October, 2021 / Leukemia CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness R. Lewis H.C. Maurer N. Singh I. Gonzalez-Menendez M. Wirth M. Schick L. Zhang K. Isaakidis A.K. Scherger V. Schulze J. Lu T. Zenz K. Steiger R. Rad L. Quintanilla-Martinez M. Espeli K. Balabanian U. Keller S. Habringer August 21, 2021 / EJNMMI Res Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients R. Lewis S. Habringer M. Kircher M. Hefter C.A. Peuker R. Werner V. Ademaj-Kospiri A. Gäble W. Weber H.J. Wester A. Buck P. Herhaus C. Lapa U. Keller January, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt October 12, 2021 / EJNMMI Res Rationale for MYC imaging and targeting in pancreatic cancer G. Schneider M. Wirth U. Keller D. Saur Pagination First page « First Previous page ‹ Previous … Page 7 Page 8 Current page 9 Page 10 Next page Next › Last page Last »
February 28, 2023 / Blood Adv SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma G.J.J.E. Heynen F. Baumgartner M. Heider U. Patra M. Holz J. Braune M. Kaiser I. Schäffer S.A. Bamopoulos E. Ramberger A. Murgai Y.L.D. Ng U.M. Demel D. Laue S. Liebig J. Krüger M. Janz A. Nogai M. Schick P. Mertins S. Müller F. Bassermann J. Krönke U. Keller M. Wirth
November 05, 2021 / Front Oncol Survey of long-term experiences of sperm cryopreservation in oncological and non-oncological patients: usage and reproductive outcomes of a large monocentric cohort N. Lackamp I. Wilkemeyer I. Jelas U. Keller L. Bullinger S. Stintzing P. le Coutre
October, 2021 / Hemasphere The mTOR inhibitor temsirolimus added to rituximab combined with dexamethasone, cytarabine, and cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL - results from the phase-II STORM trial M. Witzens-Harig A. Viardot U. Keller J. Wosniok O. Deuster J. Klemmer A.M. Geueke J. Meißner A.D. Ho J. Atta R. Marks P. La Rosée C. Buske M.H. Dreyling G. Hess
February, 2022 / Leuk Lymphoma Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial D. Kaddu-Mulindwa V. Lesan C. Berdel S. Stilgenbauer M. Bewarder L. Thurner M. Witzens-Harig A. Viardot M. Soekler U. Keller L. Truemper K. Christofyllakis O. Fleser J.T. Bittenbring V. Poeschel G. Held P. Jagoda
January 25, 2022 / Blood Adv MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma J. Stroh A. Seckinger M. Heider M. Rudelius R. Eichner M. Schick J. Slawska M. Emde H. Salwender U. Bertsch H. Goldschmidt K.C. Weisel C. Scheid U. Keller D. Hose F. Bassermann
October, 2021 / Leukemia CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness R. Lewis H.C. Maurer N. Singh I. Gonzalez-Menendez M. Wirth M. Schick L. Zhang K. Isaakidis A.K. Scherger V. Schulze J. Lu T. Zenz K. Steiger R. Rad L. Quintanilla-Martinez M. Espeli K. Balabanian U. Keller S. Habringer
August 21, 2021 / EJNMMI Res Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients R. Lewis S. Habringer M. Kircher M. Hefter C.A. Peuker R. Werner V. Ademaj-Kospiri A. Gäble W. Weber H.J. Wester A. Buck P. Herhaus C. Lapa U. Keller
January, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt
October 12, 2021 / EJNMMI Res Rationale for MYC imaging and targeting in pancreatic cancer G. Schneider M. Wirth U. Keller D. Saur